Literature DB >> 32140078

Multiple trauma including pelvic fracture with multiple arterial embolization: an autopsy case report.

Takahito Miyake1, Hideshi Okada1, Norihide Kanda1, Fuminori Yamaji1, Haruka Okamoto1, Hiroaki Ushikoshi1, Kei Noguchi2, Hiroyuki Tomita2, Shozo Yoshida1, Shinji Ogura1.   

Abstract

BACKGROUND: Pelvic fracture with high energy trauma has a high mortality rate, especially in men. In addition, severe multiple trauma, major hemorrhage, and administration of red blood cells predict mortality in elderly patients with pelvic fracture. We herein report a rare case in which multiple arterial embolization occurred after pelvic fracture. CASE
PRESENTATION: An 83-year-old male cyclist was transported to our hospital after being struck by a car. On arrival, he was diagnosed with multiple trauma, including rib fractures with hemothorax, lumbar fractures of the transverse process, and injuries in the right acetabulum, left adrenal gland, and liver. He underwent massive transfusion and transcatheter arterial embolization due to extravasation from the right superior gluteal artery and left adrenal gland. On the second day, owing to right lower leg ischemia, serum creatinine kinase and myoglobin levels were markedly elevated from the reference value; hence, a right above-knee amputation was performed 12 h after the accident. However, both protein levels remained high after amputation, resulting in acute renal injury, which was treated via hemodiafiltration on hospital day 3. In addition, sustained low efficiency hemodialysis and plasma exchange were performed on hospital day 4. Despite these treatments, the patient's hemodynamics did not improve, and he died on hospital day 8. The autopsy revealed necropsy of the iliopsoas muscles and the digestive tract.
CONCLUSIONS: The causes of the patient's death were considered to be persistent rhabdomyolysis and severe hypotension due to iliopsoas necrosis and peritonitis due to digestive tract necrosis. Multiple arterial embolization caused by consumption coagulopathy associated with multiple trauma may account for severe outcomes in this case.
© The Author(s) 2020.

Entities:  

Keywords:  Arterial embolization; Coagulopathy; Fibrinolysis; Pelvic fracture

Year:  2020        PMID: 32140078      PMCID: PMC7050116          DOI: 10.1186/s12959-020-00217-y

Source DB:  PubMed          Journal:  Thromb J        ISSN: 1477-9560


Background

Pelvic fracture with high energy trauma has a high mortality rate, especially in men [1]. It can lead to severe multiple trauma or major hemorrhage and may require administration of red blood cells [1, 2]. Its complications, especially in elderly patients, include diabetes, cardiovascular disease, and chronic kidney disease. Chronic diseases sometimes influence the treatment outcomes of patients with pelvic fracture. We report a case in which multiple arterial embolization occurred after pelvic fracture.

Case presentation

An 83-year-old male cyclist was transported to our hospital 3 h after being struck by a car. He had a medical history of acute coronary syndrome, for which he had received aspirin. His vital signs were as follows: respiratory rate, 22 breaths per minute; oxygen saturation on room air, 96%; systolic blood pressure, 125/67 mmHg; pulse rate, 88 beats per minute; and body temperature, 36.1 °C. On arrival, the patient was diagnosed with multiple trauma including multiple rib fractures with hemothorax, lumbar fractures of the transverse process, and injuries to the right acetabulum, left adrenal gland, left ureter, and liver. His injury severity score was 22. We also found extravasation of the right superior gluteal artery and left adrenal gland. He was treated with a transfusion of red blood cells, plasma, and platelets, and the ratio was 12:26:30. He was administered 1 g tranexamic acid when he presented in this very acute phase. He also required intubation and transcatheter arterial embolization. There was no evidence of stray embolic materials in the external iliac arteries. Laboratory test findings (normal ranges in parentheses) on hospital day 1 were as follows: white blood cells, 22.08 × 103/μL (3.3–8.6 × 103/μL); serum hemoglobin, 11.7 mg/dL (13.7–16.8 mg/dL); platelets, 136 × 103/μL (158–348 × 103/μL); serum creatinine kinase, 554 U/L (59–248 U/L); partial thromboplastin time, 37 s (25–38 s); international normalized ratio, 1.31; prothrombin time, 15.8 s (9.8–12.1 s); serum fibrinogen, 107 mg/dL (200–400 mg/dL); serum D-dimer, 155.7 μg/mL (< 1.0 μg/mL); and serum fibrinogen degradation products (FDPs), 305.5 μg/mL (< 5.0 μg/mL). Arterial blood gas analysis revealed mixed acidosis with an elevated serum lactate level (FiO2, 0.50; pH, 7.186; pCO2, 49.4 Torr; pO2 89.1 Torr; HCO3, 18 mmol/L; base excess − 9.9; and lactate, 44 mg/dL). On hospital day 2, his serum creatine kinase was markedly elevated to 22,001 U/L. At this point, his right lower leg showed signs of ischemia including lack of a pulse in the right dorsalis pedis artery and cold leg. These findings suggested arterial embolization in the right thigh, and 12 h after the injury, a right above-knee amputation was performed. However, the serum creatine kinase, 44,229 U/L and myoglobin levels, 67,000 ng/mL (< 110 ng/mL), were markedly high, even after the amputation, resulting in acute renal injury, which was treated via hemodiafiltration on hospital day 3. In addition, sustained low efficiency hemodialysis and plasma exchange were performed on hospital day 4. The patient’s creatine kinase and myoglobin levels are plotted against his time course of treatment in Fig. 1. The changes in hemostatic markers are shown in Table 1. Despite these treatments, the patient’s hemodynamic status, which included high catecholamine levels, did not improve, and he died on hospital day 8.
Fig. 1

Time course of treatment. CK: creatinine kinase, Plt: platelets, Myo, myoglobin, OP: operation, HDF: hemodiafiltration, PE: plasma exchange, SLED: sustained low efficiency dialysis

Table 1

The Changes of Hemostatic Markers

Day1Day2Day 3Day 4Day 5
PlateletX103/μL13646506574
PT timeseconds3734.73232.268.6
PT-INR1.311.1211.061.07
Fibrinogenmg/dL107199351553692
FDPμg/mL305.5116.970.626.517.7
D-dimerμg/mL155.751.328.710.25.7

PT: Prothrombin, PT-INR: Prothrombin-International normalized ratio, FDP: Fibrin degradation product

Time course of treatment. CK: creatinine kinase, Plt: platelets, Myo, myoglobin, OP: operation, HDF: hemodiafiltration, PE: plasma exchange, SLED: sustained low efficiency dialysis The Changes of Hemostatic Markers PT: Prothrombin, PT-INR: Prothrombin-International normalized ratio, FDP: Fibrin degradation product We performed an autopsy 50 h after his death. A general postmortem examination revealed pulmonary effusion and alveolar hemorrhage. Liver congestion and fatty liver were observed, as were tubular necrosis and nephrosclerosis in the kidney. There were also signs of arteriosclerosis in the aorta, common iliac arteries, and coronary artery. Necrosis was more severe in the left iliopsoas muscle than in the right. Although there were no signs of initial gastrointestinal tract injuries, irreversible ischemic colitis from the descending colon to the rectum was revealed. In addition, thrombus becoming fibrinized was detected in multiple organs in the autopsy specimen. (Fig. 2). This may explain the peritonitis and sepsis, which resulted in continued shock and ultimately death.
Fig. 2

Multiple organ embolization in autopsy specimen. a Thyroid gland, (b) Left ventricle with atrophic change, (c) Left ventricle with non-atrophic change, (d) Lung, (e) Kidney, (f) Pancreas, (g) Spleen, (h) Transversus Colon, (i) Iliopsoas muscle. Arrows indicate thrombus becoming fibrinized. Bars: 50 μm

Multiple organ embolization in autopsy specimen. a Thyroid gland, (b) Left ventricle with atrophic change, (c) Left ventricle with non-atrophic change, (d) Lung, (e) Kidney, (f) Pancreas, (g) Spleen, (h) Transversus Colon, (i) Iliopsoas muscle. Arrows indicate thrombus becoming fibrinized. Bars: 50 μm

Discussion and conclusions

The causes of the patient’s death were considered to be persistent rhabdomyolysis due to iliopsoas necrosis and severe hypotension due to digestive tract necrosis and consequent septic peritonitis. Multiple arterial embolization caused by the consumption coagulopathy arising from multiple trauma may be responsible for the acute embolization in multiple organs (Fig. 3). This was a very rare case of pelvic fracture with multiple organ thrombosis.
Fig. 3

Presumed mechanism of death. Rt: right, MOF: multiple organ failure

Presumed mechanism of death. Rt: right, MOF: multiple organ failure Acute traumatic coagulopathy develops in approximately 25% of severely injured individuals. It increases the risk of multisystem organ failure substantially and the risk of death by 4-fold [3]. “Trauma-induced coagulopathy” is the generally accepted term for coagulopathy in patients with massive hemorrhage and multiple trauma. It is an endogenous hypocoagulable state unrelated to iatrogenic events. Several distinct but highly integrated mechanisms have been implicated in trauma-induced coagulopathy; these include those resulting in protein C activation, platelet deficit and dysfunction, endothelial involvement, and microparticle formation. The protein C pathway is considered to be a key mediator of traumatic-induced coagulopathy owing to its downstream effects (e.g., thrombin diversion, deactivation of coagulation factors, and de-repression of fibrinolysis) [4]. The most common coagulation disorder after injury is hypercoagulability. Hypofibrinolysis or fibrinolysis shutdown is an integral component of postinjury hypercoagulopathy [3] and is an independent predictor of adverse outcomes after injury, including death [4]. In a previous report, persistent fibrinolysis shutdown independently predicted mortality with an odds ratio of 8.48 (p = 0.022) [3]. In reports in which fibrinolysis phenotypes were stratified via thromboelastography (TEG), fibrinolysis shutdown, physiologic fibrinolysis, and hyperfibrinolysis were defined as ≤0.8%, 0.8–3, and > 3% of clot lysis at 30 min after maximum clot strength, respectively [5, 6]. Recent prospective cohort data suggest that severely injured patients more often present with fibrinolysis shutdown than with hyperfibrinolysis or physiologic fibrinolysis [4]. Although we did not perform TEG in this case, we presume that fibrinolysis shutdown was the key mechanism underlying the multiple embolisms in our case. Initial D-dimer and FDP levels were significantly higher than normal, which suggests that the hypercoagulopathy in the very acute phase. It is very rare that multiple arterial embolization occurs after multiple trauma, while acute traumatic coagulopathy is often caused by severe trauma. This might explain why severely injured patients could die from hypercoagulation during the acute phase of trauma and may account for the paucity of pelvic fractures associated with multiple arterial emboli in the literature. In this case, the aspirin the patient had received for acute coronary syndrome may have affected the hypercoagulation status, allowing him to survive for several days after his injury. Several studies have investigated the effect of antiplatelet therapy in critically ill patients [7-11]. In the meta-analysis by Du et al., aspirin administration correlated with low hospital mortality rates in critically ill patients [7]. Several observational studies have shown that antiplatelet drugs reduce the levels of biomarkers such as C-reactive protein, soluble CD62P, CD54, and pro-inflammatory cytokines [8, 9]. Other studies, however, found that aspirin did not lower mortality [10] or improve acute lung injuries [11]. Although the role of aspirin in patients in intensive care units is still controversial, aspirin may have some benefits in acute critical situations [7-11]. In addition, this patient’s serum lactate was classified as mixed acidosis. It was thought that the mechanism of this acidosis was mainly from a diabetic origin such as microangiopathy. In conclusion, severe inflammation caused by severe trauma might cause multiple emboli by inducing hypercoagulation and can sometimes leads to death. Our study highlights the confirmation of hypercoagulation in autopsy. In such situations, anticoagulation therapy may prolong survival.
  11 in total

1.  Predictors of mortality for complex fractures of the pelvic ring in the elderly: a twelve-year review from a German level I trauma center.

Authors:  Ishaq Ojodu; Tim Pohlemann; Sascha Hopp; Mika F R Rollmann; Joerg H Holstein; Steven C Herath
Journal:  Injury       Date:  2015-08-03       Impact factor: 2.586

2.  Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients.

Authors:  Daryl J Kor; Jason Erlich; Michelle N Gong; Michael Malinchoc; Rickey E Carter; Ognjen Gajic; Daniel S Talmor
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

3.  Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients.

Authors:  Hunter B Moore; Ernest E Moore; Ioannis N Liras; Eduardo Gonzalez; John A Harvin; John B Holcomb; Angela Sauaia; Bryan A Cotton
Journal:  J Am Coll Surg       Date:  2016-01-22       Impact factor: 6.113

4.  Antiplatelet Therapy for Critically Ill Patients: A Pairwise and Bayesian Network Meta-Analysis.

Authors:  Fangbing Du; Pan Jiang; Shengteng He; Dongming Song; Feng Xu
Journal:  Shock       Date:  2018-06       Impact factor: 3.454

Review 5.  Coagulopathy of Trauma.

Authors:  Mitchell J Cohen; S Ariane Christie
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

6.  Persistent Fibrinolysis Shutdown Is Associated with Increased Mortality in Severely Injured Trauma Patients.

Authors:  Jonathan P Meizoso; Charles A Karcutskie; Juliet J Ray; Nicholas Namias; Carl I Schulman; Kenneth G Proctor
Journal:  J Am Coll Surg       Date:  2016-12-23       Impact factor: 6.113

7.  High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial.

Authors:  Michael Weber; Deepak L Bhatt; Danielle M Brennan; Graeme J Hankey; Steven R Steinhubl; S Claiborne Johnston; Gilles Montalescot; Koon-Hou Mak; Keith A A Fox; Donald J Easton; Eric J Topol; Christian W Hamm
Journal:  Heart       Date:  2011-03-10       Impact factor: 5.994

8.  Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Michael P Chapman; Theresa L Chin; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

Review 9.  Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients.

Authors:  Joseph B Muhlestein
Journal:  Thromb Haemost       Date:  2009-11-13       Impact factor: 5.249

10.  Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study.

Authors:  Shmeylan A Al Harbi; Hani M Tamim; Hasan M Al-Dorzi; Musharaf Sadat; Yaseen M Arabi
Journal:  BMC Pharmacol Toxicol       Date:  2016-02-05       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.